|
|||
|
|||
|
|||
|
|
Surgeons can be lionized for pushing bounds. But not always. |
While patients might express great unhappiness with most doctors if their treatment takes a sudden and uncertain turn, the public and popular media long have lionized surgeons for their dramatic responses to operating room crises. Indeed, surgeons have built lucrative practices based on their reputation in handling specialized and difficult cases. They have pushed traditional bounds of practice, often to patients’ benefits. At the same, though, their trial-and-error methods to improve their field is subject to far less oversight, say, as compared with prescription medications, as researchers have noted in published studies: “Before their release for use in the public, new prescription drugs must be of proven efficacy and safety, demonstrated in randomized controlled trials, under regulations enforced by entities such as the U.S. Food and Drug Administration or the EU European Medicines Agency or directives issued by bodies such as the International Conference on Harmonisation. “Conversely, new invasive therapeutic procedures are often launched and widely disseminated on the basis of clinical theories emerging from laboratory research, clinicopathological correlations, and weak human-studies designs from which no causal inferences should be made, with no regulatory body in charge of pre-dissemination oversight. (Medical devices are regulated but not the procedures in which they are used.) When randomized trials of an invasive procedure are conducted, it is often after the procedure has been widely used—in some cases in hundreds of thousands of patients—and doubts have emerged about its utility.” Still, as discussed above, transplants have gone from rare, headline-capturing surgeries by pioneering specialists to frequent operations. Surgeons also have pioneered less painful and invasive techniques, notably laparoscopic surgery that features “keyhole” cuts and possibly local pain relief, sparing patients from sizable incisions, scarring, and extensive anesthesia. Heart surgeons have advanced their field, so that they can still the beating heart and operate directly on this crucial organ, deploying sophisticated machinery that pumps the blood and sustains patients’ lives. They also can thread tiny cameras, robotic surgical tools, and even intricately folding valves through distant blood vessels in the wrist or groin as they make extensive repairs to the heart. Surgeons now tap an array of technologies to treat tumors and highly specific areas of the brain, giving patients new options in dealing with neurologic disorders and deadly and debilitating diseases. Neurosurgeons have made major headway in treating once-fearsome conditions that can damage the brain such as strokes and cancer. Orthopedic surgeons and neurosurgeons at the same time also have drawn increasing regulatory and media scrutiny for building financial empires based less on their operating skill and more on their acumen in designing, promoting, and selling an array of surgical hardware used to repair and replace knees, shoulders, necks, and spines. Questions also increase by the day as surgeons press hospitals to spend $1 million or more annually on robotic devices that specialists say make them more comfortable during long procedures. Critics say robotic surgical machines make operations longer and more costly — and a growing body of research says the devices show little benefit to patients. News media have reported patient harms blamed on robots. The rise of laparoscopic surgery for women, meantime, has become an increasing concern. Regulators, for example, stepped in — in tardy fashion, critics say — as news organizations reported increasing numbers of women suffering surprising cancers after “key-hole” gynecological procedures. Studies have zeroed in on a key aspect of the surgeries that may be to blame — the use of a morcellator or grinder to quickly deal with unwanted tissues resulting from laparoscopic procedures such as hysterectomies. The devices are supposed to not only macerate but remove the material. They may, instead, spread them throughout the abdominal cavity and into the bloodstream, pushing cancer cells as a consequence and causing fatal metastatic cancer. The FDA since has warned surgeons about laparoscopic gynecological procedures altogether, as well as specialists’ attempts to expand robot-assisted breast operations. When surgeons promoted and sought to expand what many believed was an important procedure for those with serious weight problems, state regulators were forced to step in, cracking down on pop-up clinics performing the lap-band operation. Five patients died after undergoing the procedure, in which surgeons band off part of the stomach to restrict patients’ food intake and cause them to drop weight. While this operation was heavily advertised — and in the case of problematic clinics in California not optimally performed or monitored — surgeons eventually let this approach fall by the wayside. Its advantage was that it could be reversed. But its results over the longer term turned out to be disappointing. Instead, surgeons now tend to perform either a gastric bypass or sleeve procedure, operations that both reduce the size of the stomach permanently and can be done laparoscopically. These are serious operations for those with significant obesity and require patients’ long-term commitment to diet and lifestyle changes. |
Recent Health Care Blog Posts |
Here are some recent posts on our patient safety blog that might interest you:
|
HERE’S TO A HEALTHY REST OF 2021!
|
Sincerely, Patrick Malone |